These data suggest that IL-33 represents an important bone-protecting cytokine which may be a novel therapeutic tool in the prevention and therapy of osteoporosis in postmenopausal women and treatment with recombinant IL-33 could be useful for future strategies against osteoporosis. This evidence concerns the gene IL33 and osteoporosis.